Recent Progress on Nanomedicine‐Mediated Repolarization of Tumor‐Associated Macrophages for Cancer Immunotherapy
WIREs Nanomedicine and Nanobiotechnology · 2024-09 · 16 (5)
DOI: 10.1002/wnan.2001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 19.10.2024. Verfasst von Jing-Yang Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, China. Hauptthemen laut MEDLINE: Immunotherapy, Nanomedicine, Tumor-Associated Macrophages, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 181 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, the Program of Science and Technology Planning Project of Ganzhou.
Abstract (Originalsprache)
Tumor‐associated macrophages (TAMs) constitute the largest number of immune cells in the tumor microenvironment (TME). They play an essential role in promoting tumor progression and metastasis, which makes them a potential therapeutic target for cancer treatment. TAMs are usually divided into two categories: pro‐tumoral M2‐like TAMs and antitumoral M1 phenotypes at either extreme. The reprogramming of M2‐like TAMs toward a tumoricidal M1 phenotype is of particular interest for the restoration of antitumor immunity in cancer immunotherapy. Notably, nanomedicines have shown great potential for cancer therapy due to their unique structures and properties. This review will briefly describe the biological features and roles of TAMs in tumor, and then discuss recent advances in nanomedicine‐mediated repolarization of TAMs for cancer immunotherapy. Finally, perspectives on nanomedicine‐mediated repolarization of TAMs for effective cancer immunotherapy are also presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, China.
- School of Medicine, South China University of Technology, Guangzhou, China.
- Department of Gastrointestinal Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, China.
- Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, China.
ORCID-Profile: Jin-Zhi Du
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- the Program of Science and Technology Planning Project of Ganzhou
- Central University Basic Research Fund of China
- Postdoctoral Fellowship Program of CPSF
Zitieren
APA
Zhang, J. Y., Su, Y. H., Wang, X., Yao, X., & Du, J. Z. (2024). Recent Progress on Nanomedicine‐Mediated Repolarization of Tumor‐Associated Macrophages for Cancer Immunotherapy. WIREs Nanomedicine and Nanobiotechnology, 16(5). https://doi.org/10.1002/wnan.2001
Vancouver
Zhang JY, Su YH, Wang X, Yao X, Du JZ. Recent Progress on Nanomedicine‐Mediated Repolarization of Tumor‐Associated Macrophages for Cancer Immunotherapy. WIREs Nanomedicine and Nanobiotechnology. 2024;16(5). doi:10.1002/wnan.2001
BibTeX
@article{Zhang2024,
author = {Zhang, Jing-Yang and Su, Yun-He and Wang, Xu and Yao, Xueqing and Du, Jin-Zhi},
title = {Recent Progress on Nanomedicine‐Mediated Repolarization of Tumor‐Associated Macrophages for Cancer Immunotherapy},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
volume = {16},
number = {5},
doi = {10.1002/wnan.2001}
}
EUVIMED